Cyclacel Pharmaceuticals, Inc. Email Format
Biotechnology ResearchNew Jersey, United States2-10 Employees
Cyclacel Pharmaceuticals, Inc. is a small biotechnology firm based in Berkeley Heights, New Jersey, focused on developing therapies that target cell cycle control to treat cancer and other serious diseases. The company pursues a diversified portfolio of novel drug candidates to address areas of high unmet medical need in oncology and related conditions. Its research targets a range of solid tumors and hematologic cancers within the biopharmaceutical field. In early 2024 the company announced the appointment of Brian Schwartz, M.D., as Chief Medical Officer, reflecting ongoing leadership development. Cyclacel trades on NASDAQ under the ticker symbols CYCC and CYCCP.